Search

everythinglearnresearchcommunity

for

Search:↓

Riboflavin 5′-phosphate (FMN) shows potential for treating androgen-related conditions but may be limited in treating prostate cancer.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

Certain microRNAs are more common in balding areas and might be involved in male pattern baldness.

Fadrozole and finasteride change gene expression related to sex hormones and thyroid hormones in frog larvae development.

Men generally have more severe COVID-19 cases and higher death rates than women due to biological differences.

Certain drugs can worsen hair loss in people prone to androgenetic alopecia.

Ganoderma lucidum extract may help treat stress-related hair loss.

The study found that certain microRNAs are higher in the cells and lower in the fluid of women with a specific type of polycystic ovary syndrome, and one microRNA could potentially help diagnose the condition.

Lowering testosterone speeds up wound healing in male mice.

Male hormones and their receptors play a key role in hair loss and skin health, with potential new treatments being explored.

The balance between androgen receptor and p53 is crucial for sebaceous gland differentiation.

Androgen receptor activity blocks Wnt/β-catenin signaling, affecting hair growth and skin cell balance.

Androgen receptor signaling causes early aging of cells important for hair growth by damaging their DNA.

Blocking the androgen receptor in skin cells reduces their growth response to male hormones, suggesting a possible treatment for skin conditions linked to androgens.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

Finasteride may improve prostate cancer treatment outcomes.

The Androgen Receptor could be a target for treating diseases like cancer, but more research is needed to confirm the effectiveness of potential treatments.

The study concluded that both estrogen and androgen receptors, which decrease with age, are linked to skin aging and may be hormonally regulated.

Fluridil promotes hair growth safely and effectively for androgenetic alopecia.

Different substances that activate or block the androgen receptor can affect male development and treat conditions like prostate cancer.

Androgen receptors in the mouse brain may explain cognitive and mood changes in prostate cancer treatment.

Androgens and androgen receptors are important for metabolic health, affecting how the body uses glucose and fats through mitochondrial function.

ERG increases SOX9, promoting prostate cancer growth and invasion.

The conclusion is that a treatment called cp-asiAR can reduce hair loss and promote hair growth, making it a potential new therapy for androgenetic alopecia.

cp-asiAR may effectively treat hair loss by targeting androgen receptors.

The study found that androgen receptors in skin cells mainly affect the focal adhesion pathway and control the caveolin-1 gene, with implications for new treatments for related diseases.

Adenosine complex helps increase hair thickness and density in hair loss.

New treatments targeting androgen receptors show promise for drug-resistant prostate cancer.

Chromosomal differences affect how muscle cells respond to testosterone.

NcoA4 may have roles beyond helping control gene activity, possibly affecting cell behavior and stability.